我们的产品管线
Program
Targets
Fomats
Indication
IND
Early Clinical
Late Clinical
Partnership
TJ101
EGFR XB7H3
Bispecific ADC
NSCLC, HNSCC, etc
TJ102
FRa x CDH6
Bispecific dual payload ADC
OC, RCC etc
TJ106
HER2 x HER2
Bispecific dual payload ADC
Breast Cancer (pan-Her2)
TJ108
EGFR x HER3
Bispecific dual payload ADC
NSCLC etc
TJ101
EGFR XB7H3
Bispecific ADC
NSCLC, HNSCC, etc
IND
Early Clinical
Late Clinical
TJ102
FRa x CDH6
Bispecific dual payload ADC
OC, RCC etc
IND
Early Clinical
Late Clinical
TJ106
HER2 x HER2
Bispecific dual payload ADC
Breast Cancer (pan-Her2)
IND
Early Clinical
Late Clinical
TJ108
EGFR x HER3
Bispecific dual payload ADC
NSCLC etc
IND
Early Clinical
Late Clinical
